Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung Cancer
Clinical trial NCT04833205 · UNKNOWN
Trial details
- NCT number
- NCT04833205
- Sponsor
- Hui Bu
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-19
- Primary completion
- 2022-04-19
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.